Traditionally, this has involved artificial heart valves, similar to those used in the treatment of adults. But these have several serious disadvantages: Firstly, artificial heart valves don’t grow with the children, they are also frequently rejected – this means in following years, additional operations are necessary to replace them. Moreover, children need to take blood-thinning medication.
Over ten years ago, the clinic began to research a visionary alternative: the children should receive real, decellularized heart valves from human donors. This entails chemically removing the proteins of the donors from the heart valves.
We are delighted that Telekom Healthcare Solutions has developed a system that securely combines pseudonymized MRI and study data.
Dr. Samir Sarikouch, clinical study leader and senior physician at Hannover Medical School
“These requirements are obvious – but such a system was not available on the market”, explains Dr. Samir Sarikouch, clinical study leader and senior physician at MHH. A large part of the research was still carried out manually. For the clinic, this approach was not acceptable for an international project. The study system TrialComplete, developed at that time by Telekom Healthcare Solutions, enables the pseudonymization and archiving of medical and image data in a standardized data format (DICOM) and therefore supports the study process. Access to the web application takes place over the internal clinic PC via Client – this also applies for the clinics taking part in the study in other European countries. Installation or the purchase of licenses is not necessary. The application itself is operated in a T-Systems data center. This means also in terms of infrastructure, all security and data protection requirements are fulfilled. So for ESPOIR, TrialComplete was the perfect option. “TrialComplete offers researching scientists a ‘single point of truth’ – data is stored centrally and can also be sorted and processed by us. We can immediately see the filtered data sets and start working”, Dr. Sarikouch summarizes. Through its operation on a private cloud, TrialComplete is scalable. If the number of participants in a study dramatically increases, the cloud can make additional resources available, thereby securing a user-friendly working experience.